Nanosphere Health Sciences (FRA:2CG) Cyclically Adjusted PB Ratio: (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nanosphere Health Sciences Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nanosphere Health Sciences  (FRA:2CG) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Nanosphere Health Sciences Cyclically Adjusted PB Ratio Related Terms


Nanosphere Health Sciences Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Nanosphere Health Sciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanosphere Health Sciences Cyclically Adjusted PB Ratio Chart

Nanosphere Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.01 0.00 1.41 0.46

Nanosphere Health Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.71 0.66 0.58 0.46 0.00

FRA:2CG vs VRTX, REGN, MRNA: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Nanosphere Health Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosphere Health Sciences Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's Cyclically Adjusted PB Ratio falls into.



Nanosphere Health Sciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Nanosphere Health Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Nanosphere Health Sciences's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.119/133.5265*133.5265
=-0.119

Current CPI (Jun. 2026) = 133.5265.

Nanosphere Health Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.228 102.002 -0.298
201609 0.670 101.765 0.879
201612 -0.261 101.449 -0.344
201703 0.584 102.634 0.760
201706 0.531 103.029 0.688
201709 0.844 103.345 1.090
201712 0.647 103.345 0.836
201803 0.466 105.004 0.593
201806 0.371 105.557 0.469
201809 0.217 105.636 0.274
201812 0.145 105.399 0.184
201903 0.267 106.979 0.333
201906 0.175 107.690 0.217
201909 0.071 107.611 0.088
201912 -0.153 107.769 -0.190
202003 -0.182 107.927 -0.225
202006 -0.197 108.401 -0.243
202009 -0.199 108.164 -0.246
202012 -0.221 108.559 -0.272
202103 -0.236 110.298 -0.286
202106 -0.254 111.720 -0.304
202109 -0.083 112.905 -0.098
202112 -0.093 113.774 -0.109
202203 -0.102 117.646 -0.116
202206 -0.112 120.806 -0.124
202209 -0.119 120.648 -0.132
202212 -0.121 120.964 -0.134
202303 -0.124 122.702 -0.135
202306 -0.131 124.203 -0.141
202309 -0.135 125.230 -0.144
202312 -0.139 125.072 -0.148
202403 -0.141 126.258 -0.149
202406 -0.147 127.522 -0.154
202409 -0.148 127.285 -0.155
202412 -0.113 127.364 -0.118
202503 -0.118 129.181 -0.122
202506 -0.117 129.892 -0.120
202509 -0.114 130.287 -0.117
202512 -0.112 130.366 -0.115
202606 -0.119 133.527 -0.119

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nanosphere Health Sciences Business Description

Other Exchanges NSHSF:USANSHS:Canada
Address 605 Robson Street, c/o Suite 430, Vancouver, BC, CAN, V6B 5J3
Nanosphere Health Sciences Inc is a biotechnology company focused on providing next generation delivery of biologically active compounds through licensing and joint venture arrangements. The Company has developed and is commercializing its patented NanoSphere Delivery System, a nanotechnology platform for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The NanoSphere Delivery System provides improved bioavailability, efficacy, and onset of effect over traditional delivery systems.